EndoS / Hansa Biopharma - LARVOL DELTA

Diabetic Gastroparesis: Principles and Current Trends in Management. (PubMed, Diabetes Ther) - "...Selected medication-refractory patients with DGp may benefit from gastric neuromodulation, and some from surgical interventions including pyloric therapies that can also be done endoscopically. As is true of any of the diabetic complications, prevention of DGp by early and optimal glycemic control is more cost-effective. Hansa Medcell, India."

Journal • Review • Biosimilar • CNS Disorders • Diabetes • Gene Therapies • Genetic Disorders • Metabolic Disorders • Pain